相似文献
1
Genetically engineered mouse models of melanoma.
Cancer. 2017 Jun 1;123(S11):2089-2103. doi: 10.1002/cncr.30684.
2
Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models.
Int J Oncol. 2005 May;26(5):1233-9.
3
Modeling cancer using genetically engineered mice.
Methods Mol Biol. 2015;1267:3-18. doi: 10.1007/978-1-4939-2297-0_1.
4
Molecular biology of malignant melanoma.
Adv Exp Med Biol. 2008;624:252-64. doi: 10.1007/978-0-387-77574-6_20.
5
UV exposure, genetic targets in melanocytic tumors and transgenic mouse models.
Photochem Photobiol. 2005 Jan-Feb;81(1):52-64. doi: 10.1562/2004-09-26-IR-328.
6
Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model.
Photochem Photobiol Sci. 2006 Feb;5(2):254-60. doi: 10.1039/b506974b. Epub 2005 Jul 27.
7
UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.
Adv Exp Med Biol. 2008;624:162-78. doi: 10.1007/978-0-387-77574-6_13.
8
Development of a new mouse model (xeroderma pigmentosum a-deficient, stem cell factor-transgenic) of ultraviolet B-induced melanoma.
J Invest Dermatol. 2005 Sep;125(3):521-5. doi: 10.1111/j.0022-202X.2005.23753.x.
9
Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression.
Oncogene. 2015 May 28;34(22):2879-86. doi: 10.1038/onc.2014.227. Epub 2014 Aug 4.
10
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.
Int J Cancer. 2006 Jan 15;118(2):373-80. doi: 10.1002/ijc.21349.
引用本文的文献
1
Preclinical models in the study of lymph node metastasis.
J Zhejiang Univ Sci B. 2025 Jun 24;26(8):740-762. doi: 10.1631/jzus.B2400052.
2
Transcriptional reprogramming triggered by neonatal UV radiation or Lkb1 loss prevents BRAF-induced growth arrest in melanocytes.
Oncogene. 2025 Jun;44(21):1592-1608. doi: 10.1038/s41388-025-03339-7. Epub 2025 Mar 8.
3
Generation of a genetically engineered porcine melanoma model featuring oncogenic control through conditional Cre recombination.
Sci Rep. 2025 Jan 10;15(1):1616. doi: 10.1038/s41598-024-82554-w.
4
Aspects and prospects of preclinical theranostic radiopharmaceutical development.
Theranostics. 2024 Oct 7;14(17):6446-6470. doi: 10.7150/thno.100339. eCollection 2024.
5
Dangerous liaisons: Loss of keratinocyte control over melanocytes in melanomagenesis.
Bioessays. 2024 Nov;46(11):e2400135. doi: 10.1002/bies.202400135. Epub 2024 Sep 4.
6
Orthotopic model for the analysis of melanoma circulating tumor cells.
Sci Rep. 2024 Apr 3;14(1):7827. doi: 10.1038/s41598-024-58236-y.
7
Twenty years of research in melanoma therapy-From "nothing works" to cures: A personal account.
Pigment Cell Melanoma Res. 2023 Nov;36(6):583-587. doi: 10.1111/pcmr.13133. Epub 2023 Sep 19.
8
Experimental Models for Rare Melanoma Research-The Niche That Needs to Be Addressed.
Bioengineering (Basel). 2023 Jun 1;10(6):673. doi: 10.3390/bioengineering10060673.
9
The role of extracellular vesicles and interleukin-8 in regulating and mediating neutrophil-dependent cancer drug resistance.
Front Oncol. 2022 Dec 16;12:947183. doi: 10.3389/fonc.2022.947183. eCollection 2022.
10
Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review.
J Clin Transl Hepatol. 2022 Oct 28;10(5):995-1003. doi: 10.14218/JCTH.2022.00086. Epub 2022 Apr 28.
本文引用的文献
1
Concepts in Cancer Modeling: A Brief History.
Cancer Res. 2016 Oct 15;76(20):5921-5925. doi: 10.1158/0008-5472.CAN-16-1293. Epub 2016 Sep 30.
2
The genomic landscape of cutaneous melanoma.
Pigment Cell Melanoma Res. 2016 May;29(3):266-83. doi: 10.1111/pcmr.12459. Epub 2016 Mar 4.
3
AKT1 Activation Promotes Development of Melanoma Metastases.
Cell Rep. 2015 Nov 3;13(5):898-905. doi: 10.1016/j.celrep.2015.09.057. Epub 2015 Oct 22.
4
Preclinical mouse cancer models: a maze of opportunities and challenges.
Cell. 2015 Sep 24;163(1):39-53. doi: 10.1016/j.cell.2015.08.068.
5
Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
Cancer Res. 2015 Aug 15;75(16):3384-97. doi: 10.1158/0008-5472.CAN-14-3229. Epub 2015 Jun 25.
6
Genomic Classification of Cutaneous Melanoma.
Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.
7
Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.
Nat Genet. 2015 May;47(5):486-95. doi: 10.1038/ng.3275. Epub 2015 Apr 13.
8
Maintenance of distinct melanocyte populations in the interfollicular epidermis.
Pigment Cell Melanoma Res. 2015 Jul;28(4):476-80. doi: 10.1111/pcmr.12375. Epub 2015 Apr 30.
9
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Cancer Cell. 2015 Jan 12;27(1):41-56. doi: 10.1016/j.ccell.2014.11.014.
10
Cancer statistics, 2015.
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
Zotero 插件